Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03271372
Title Adjuvant Avelumab in Merkel Cell Cancer (ADAM)
Acronym ADAM
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors University of Washington
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California Irvine Chao Family Comprehensive Cancer Center Orange California 92868 United States Details
University of Colorado Cancer Center University of Colorado Anschutz Medical Campus Aurora Colorado 80045 United States Details
Moffitt Cancer Center Tampa Florida 33612 United States Details
Northwestern University Chicago Illinois 60611 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
University of Michigan Comprehensive Cancer Center Ann Arbor Michigan 48109 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
University of North Carolina Lineberger Comprehensive Cancer Center Chapel Hill North Carolina 27599 United States Details
Fred Hutch/University of Washington Cancer Consortium Seattle Washington 98109 United States Details
*Shaded cells indicate that there was no data available from for the field